DB Power and LPA announce strategic partnership to globally expand solutions for issuers of structured retail products

Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

01244 3D MEDICINES

Trading Add to Porfolio
Index Constituent : HS Comp.LargeCap Ind, HS Comp. L & M Index, Stock Connect HK MS
Major Shareholders Gong Zhaolong (15.01%)
[02096] Simcere Pharmaceutical Group Limited (8.93%)
Kastle Limited (7.41%)
Shenzhen Efung Investment Management Enterprise (L.P.) (5.31%)		 Sector Health Care & Biotechnology
Web Site https://www.3d-medicines.com/ Tel (86 010) 6788-8635
Email ir@3d-medicines.com Fax N/A
Related Equities N/A
Principal Activities Principally engaged in the research and development of oncology therapies for cancer patients, especially those who require long-term care.

Consolidated List of Substantial Shareholders

Name Number of Shares Interested % of Issued Share Capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool

Complete List of Directors

Director's Name Number of Shares Interested % of issued share capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Back to Top